Bellicum Pharmaceuticals Inc (NASDAQ:BLCM)

1.77
Delayed Data
As of 4:00pm ET
 +0.03 / +1.72%
Today’s Change
1.66
Today|||52-Week Range
8.15
-49.86%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Bellicum Pharmaceuticals Inc have a median target of 4.50, with a high estimate of 4.50 and a low estimate of 4.50. The median estimate represents a +154.24% increase from the last price of 1.77.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Hold stock in Bellicum Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.57
Sales
$300.0K
Reporting Date
Mar 14

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -511.07%
 
 
 
 
 
 
Growthannually -152.99%
 
 
 
 
 
 

Sales

Growthquarterly -94.00%
 
 
 
 
 
Growthannually -100.00%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.